APP
PRAH

Avantax Planning Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Avantax Planning Partners’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-67
Closed -$7K – 1344
2018
Q3 		$7K Buy
+67
New +$6.98K ﹤0.01% 999
2018
Q2 		– Sell
-111
Closed -$9K – 1676
2018
Q1 		$9K Buy
+111
New +$9.86K ﹤0.01% 1124

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Avantax Planning Partners's PRAH Position: Q4 2018 in Review

Avantax Planning Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2018, closing a stake of 67 shares — an estimated $7K sold.

Avantax Planning Partners first reported a position in PRAH in Q1 2018 and held it in 2 quarters. The position peaked at $9K in Q1 2018. 334 funds tracked by Wall St. Rank hold PRAH as of Q4 2018.

  • Avantax Planning Partners reported no remaining PRA Health Sciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 67 PRA Health Sciences, Inc. shares in Q4 2018, an estimated $7K.
  • Avantax Planning Partners first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's PRA Health Sciences, Inc. position peaked at $9K in Q1 2018.
  • 334 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.